最後更新 2024-12-16 00:49:24 (UTC+8)
月營收分析
判斷 生技醫療業 月營收的循環週期以及成長趨勢。
醫藥產業 季節調整後月營收走勢圖
FindBillion.com
季節調整後月營收成長率
月營收月增率 | -2.8% |
月營收季增率 | -4.3% |
月營收年增率 | -4.2% |
截至2024-11-30
個股列表
醫藥產業 產業相關的個股季節調整後月營收月增率、季增率及年增率。
公司名稱 | 月營收 月增率 | 月營收 季增率 | 月營收 年增率 | 最後公告期別 | |
---|---|---|---|---|---|
6535 順藥 | 106.1% | -27.4 | -44.5% | 2024-11-30 | |
4168 醣聯 | 86.1% | 21588.5 | 369.1% | 2024-11-30 | |
6550 北極星藥業-KY | 17.5% | 109 | 1823.5% | 2024-11-30 | |
4108 懷特 | 13.7% | 6.6 | -16% | 2024-11-30 | |
4157 太景*-KY | 12.6% | 26.8 | 19.3% | 2024-11-30 | |
6712 長聖 | 11.9% | 18.8 | 19.7% | 2024-11-30 | |
4746 台耀 | 10.5% | 12.6 | 7.1% | 2024-11-30 | |
4726 永昕 | 10.3% | -37.6 | 37.7% | 2024-11-30 | |
4743 合一 | 8.4% | 43.1 | 26.4% | 2024-11-30 | |
4119 旭富 | 7% | 17.3 | 54.2% | 2024-11-30 | |
4111 濟生 | 6.1% | 11 | 16.1% | 2024-11-30 | |
4147 中裕 | 5.3% | 3.9 | -12.5% | 2024-11-30 | |
6472 保瑞 | 5% | -8.3 | -39.8% | 2023-11-30 | |
4911 德英 | 4.8% | 9.5 | 54.3% | 2024-11-30 | |
6130 上亞科技 | 4.8% | -6.6 | -10.5% | 2024-11-30 | |
5398 慕康生醫 | 3.7% | 3.7 | 91.6% | 2024-11-30 | |
1731 美吾華 | 3.4% | 3.1 | 12.1% | 2024-11-30 | |
4121 優盛 | 2.9% | - | 3% | 2024-11-30 | |
6242 立康 | 2.6% | 1.1 | -1% | 2024-11-30 | |
4104 佳醫 | 2.4% | 6.3 | 4.2% | 2024-11-30 | |
6844 諾貝兒 | 1.8% | 4.6 | -0.6% | 2024-11-30 | |
8432 東生華 | 1.4% | 76.1 | 223.8% | 2024-11-30 | |
6469 大樹 | 1.1% | 3.3 | 5.9% | 2024-11-30 | |
4173 久裕 | 0.9% | 1.7 | 18.6% | 2024-11-30 | |
6492 生華科 | 0.2% | -12.6 | - | 2024-11-30 | |
6785 昱展新藥 | - | 1900129632.7 | 627.1% | 2024-11-30 | |
6637 醫影 | -0.1% | 92.4 | 76.3% | 2024-11-30 | |
4164 承業醫 | -0.1% | 4.2 | -29.1% | 2024-11-30 | |
8403 盛弘 | -0.2% | -0.3 | 10.3% | 2024-11-30 | |
6496 科懋 | -0.4% | 1 | 11.5% | 2024-11-30 | |
4167 松瑞藥 | -0.4% | 10.9 | 8% | 2024-11-30 | |
4175 杏一 | -0.5% | -0.7 | 1.7% | 2024-11-30 | |
4114 健喬 | -0.6% | 4.6 | 12.1% | 2024-11-30 | |
4120 友華 | -0.6% | -4.6 | -3.8% | 2024-11-30 | |
4130 健亞 | -0.7% | 0.4 | -6.1% | 2024-11-30 | |
1720 生達 | -0.9% | -2.8 | 7.7% | 2024-11-30 | |
4105 東洋 | -0.9% | 5.8 | -1.4% | 2024-11-30 | |
4128 中天 | -1% | 2.3 | 6.7% | 2024-11-30 | |
4133 亞諾法 | -1% | -1.6 | -9.7% | 2024-11-30 | |
1701 | -1.3% | -4.2 | 0.6% | 2024-07-31 | |
1760 寶齡富錦 | -1.8% | -10.6 | -1.7% | 2024-11-30 | |
3176 基亞 | -2.1% | 1.3 | -8.7% | 2024-11-30 | |
3118 進階 | -3.2% | 0.1 | 0.1% | 2024-11-30 | |
1789 神隆 | -3.4% | -5.5 | -15.2% | 2024-11-30 | |
4127 天良 | -3.7% | -5.5 | -20.3% | 2024-11-30 | |
6541 泰福-KY | -3.8% | -43.5 | -37.8% | 2024-11-30 | |
1734 杏輝 | -3.9% | -8.1 | 0.5% | 2024-11-30 | |
1752 南光 | -4.2% | 3.5 | 4.9% | 2024-11-30 | |
8279 生展 | -4.5% | -3.2 | 10.3% | 2024-11-30 | |
1777 生泰 | -4.6% | -1.8 | 23.9% | 2024-11-30 | |
3705 永信 | -5% | -7.5 | 10.8% | 2024-11-30 | |
4123 晟德 | -5.2% | -10 | 14.9% | 2024-11-30 | |
4139 馬光-KY | -5.4% | -1.8 | -3.5% | 2024-11-30 | |
1795 美時 | -5.6% | -16.9 | 33.8% | 2024-11-30 | |
6576 逸達 | -6.2% | 178.1 | 98.8% | 2024-11-30 | |
4152 | -6.5% | 181.8 | 1606.2% | ||
2104 國際中橡 | -6.6% | -19.7 | -14.1% | 2024-11-30 | |
4747 強生 | -7.3% | -8.1 | -4.5% | 2024-11-30 | |
4162 智擎 | -8.2% | -24 | 19.3% | 2024-11-30 | |
6446 藥華藥 | -9.8% | -2.9 | 103.6% | 2024-11-30 | |
6589 台康生技 | -10.3% | -14.3 | -45.3% | 2024-11-30 | |
6547 高端疫苗 | -16% | -33.2 | -14.8% | 2024-11-30 | |
4192 杏國 | -18.8% | -6.8 | -13.8% | 2024-11-30 | |
1799 易威 | -20% | -31.9 | 102.1% | 2024-11-30 | |
1762 中化生 | -21.8% | -24.8 | -22.3% | 2024-11-30 | |
6617 共信-KY | -28.5% | -0.5 | 6.1% | 2024-11-30 | |
4102 永日 | -28.7% | -46.8 | -40.4% | 2024-11-30 | |
6461 益得 | -31.8% | -52 | -30.5% | 2024-11-30 | |
4142 國光生 | -31.9% | -62.7 | -28.4% | 2024-11-30 | |
4174 浩鼎 | -53.7% | -76.7 | -50.3% | 2024-11-30 | |
3716 中化控股 | - | - | - | ||
6657 華安 | - | - | - | ||
6794 向榮生技-創 | - | - | - | ||
6838 台新藥 | - | - | - | ||
6875 國邑* | - | - | - | ||
6885 全福生技 | - | - | - | ||
6901 鑽石投資 | - | - | - | ||
6919 康霈* | - | - | - | ||
6929 佑全 | - | - | - | ||
6949 沛爾生醫-創 | - | - | - |
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。